ORPP logo
Image from Google Jackets

Lyme Disease : Global Status.

By: Contributor(s): Material type: TextTextPublisher: Los Angeles : Gideon Informatics, Incorporated, 2023Copyright date: ©2023Edition: 1st edDescription: 1 online resource (152 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781498833035
Genre/Form: Additional physical formats: Print version:: Lyme Disease: Global StatusLOC classification:
  • RC155.5 .B474 2021
Online resources:
Contents:
Intro -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Lyme disease -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Vaccine -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- Albania -- Algeria -- References -- American Samoa -- Andorra -- Armenia -- Australia -- References -- Austria -- References -- Azerbaijan -- The Azores -- Belarus -- References -- Belgium -- References -- Bolivia -- References -- Bosnia and Herzegovina -- References -- Botswana -- References -- Brazil -- References -- Bulgaria -- References -- Canada -- References -- Cape Verde -- References -- Chile -- References -- China -- References -- Colombia -- References -- Costa Rica -- References -- Croatia -- References -- Cuba -- References -- Cyprus -- References -- The Czech Republic -- References -- Denmark -- References -- Ecuador -- References -- Egypt -- References -- Estonia -- References -- Ethiopia -- References -- Finland -- References -- France -- References -- Georgia -- Germany -- References -- Greece -- References -- Guam -- Guatemala -- References -- Guyana -- References -- Haiti -- References -- Hong Kong -- References -- Hungary -- References -- Iceland -- References -- India -- References -- Iran -- References -- Ireland -- References -- Israel -- References -- Italy -- References -- Japan -- References -- Jordan -- References -- Kazakhstan -- References -- Kenya -- References -- Kosovo -- References -- Laos -- References -- Latvia -- References -- Lithuania -- References -- Luxembourg -- References -- Malaysia -- References -- Malta -- Mauritius -- References -- Mexico -- References -- Moldova -- References -- Mongolia -- References.
Montenegro -- References -- Morocco -- References -- Nepal -- References -- The Netherlands -- References -- New Zealand -- Nicaragua -- References -- Nigeria -- References -- North Macedonia -- Northern Ireland -- References -- The Northern Marianas -- Norway -- References -- Panama -- References -- North Korea -- References -- Peru -- References -- The Philippines -- References -- Poland -- References -- Portugal -- References -- Puerto Rico -- References -- South Korea -- References -- Romania -- References -- The Russian Federation -- References -- San Marino -- Scotland -- References -- Serbia -- References -- Slovakia -- References -- Slovenia -- References -- South Africa -- References -- Spain -- References -- Sweden -- References -- Switzerland -- References -- Taiwan -- References -- Tajikistan -- Thailand -- References -- Trinidad and Tobago -- References -- Tunisia -- References -- Turkey -- References -- Ukraine -- References -- The United Kingdom -- References -- The United States -- References -- The U.S. Virgin Islands -- Vaccines &amp -- Immunoglobulins -- Lyme disease vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Lyme disease vaccine (6 listed) -- Contraindications for Lyme disease vaccine (4 listed) -- Trade names of Lyme disease vaccine (1 listed) -- About GIDEON.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Intro -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Lyme disease -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Vaccine -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- Albania -- Algeria -- References -- American Samoa -- Andorra -- Armenia -- Australia -- References -- Austria -- References -- Azerbaijan -- The Azores -- Belarus -- References -- Belgium -- References -- Bolivia -- References -- Bosnia and Herzegovina -- References -- Botswana -- References -- Brazil -- References -- Bulgaria -- References -- Canada -- References -- Cape Verde -- References -- Chile -- References -- China -- References -- Colombia -- References -- Costa Rica -- References -- Croatia -- References -- Cuba -- References -- Cyprus -- References -- The Czech Republic -- References -- Denmark -- References -- Ecuador -- References -- Egypt -- References -- Estonia -- References -- Ethiopia -- References -- Finland -- References -- France -- References -- Georgia -- Germany -- References -- Greece -- References -- Guam -- Guatemala -- References -- Guyana -- References -- Haiti -- References -- Hong Kong -- References -- Hungary -- References -- Iceland -- References -- India -- References -- Iran -- References -- Ireland -- References -- Israel -- References -- Italy -- References -- Japan -- References -- Jordan -- References -- Kazakhstan -- References -- Kenya -- References -- Kosovo -- References -- Laos -- References -- Latvia -- References -- Lithuania -- References -- Luxembourg -- References -- Malaysia -- References -- Malta -- Mauritius -- References -- Mexico -- References -- Moldova -- References -- Mongolia -- References.

Montenegro -- References -- Morocco -- References -- Nepal -- References -- The Netherlands -- References -- New Zealand -- Nicaragua -- References -- Nigeria -- References -- North Macedonia -- Northern Ireland -- References -- The Northern Marianas -- Norway -- References -- Panama -- References -- North Korea -- References -- Peru -- References -- The Philippines -- References -- Poland -- References -- Portugal -- References -- Puerto Rico -- References -- South Korea -- References -- Romania -- References -- The Russian Federation -- References -- San Marino -- Scotland -- References -- Serbia -- References -- Slovakia -- References -- Slovenia -- References -- South Africa -- References -- Spain -- References -- Sweden -- References -- Switzerland -- References -- Taiwan -- References -- Tajikistan -- Thailand -- References -- Trinidad and Tobago -- References -- Tunisia -- References -- Turkey -- References -- Ukraine -- References -- The United Kingdom -- References -- The United States -- References -- The U.S. Virgin Islands -- Vaccines &amp -- Immunoglobulins -- Lyme disease vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Lyme disease vaccine (6 listed) -- Contraindications for Lyme disease vaccine (4 listed) -- Trade names of Lyme disease vaccine (1 listed) -- About GIDEON.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

to post a comment.

© 2024 Resource Centre. All rights reserved.